Ayurcann HoldingsAYURF EV-to-FCF is 0.65 as of Jul. 05, 2026, which is 58% below its 10-year median of 1.54. The stock has 2 warning signs investors should review.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Ayurcann Holdings's Enterprise Value is $0.29 Mil.
Ayurcann Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 was $0.44 Mil. Therefore, Ayurcann Holdings's EV-to-FCF for today is 0.65.
The historical rank and industry rank for Ayurcann Holdings's EV-to-FCF or its related term are showing as below:
AYURF'
s EV-to-FCF Range Over the Past 10 Years
Min: -108.57 Med: 1.54 Max: 77.77
Current: 2.82
During the past 13 years, the highest EV-to-FCF of Ayurcann Holdings was 77.77. The lowest was -108.57. And the median was 1.54.
AYURF's EV-to-FCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 20.525
vs AYURF: 2.82
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Ayurcann Holdings's PE Ratio (TTM) for today is calculated as:
Ayurcann Holdings's share price for today is $0.0021.
Ayurcann Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.021.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Ayurcann Holdings EV-to-FCF Related Terms
Ayurcann Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Ayurcann Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Ayurcann Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ayurcann Holdings EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ayurcann Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Ayurcann Holdings's EV-to-FCF falls into.
Ayurcann Holdings's current Enterprise Value is $0.29 Mil.
Ayurcann Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ayurcann Holdings (AYURF) has a EV-to-FCF of 0.65 as of Jul. 05, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ayurcann Holdings and its competitors. This is 58% below median its historical median of 1.54.
Is Ayurcann Holdings' EV-to-FCF too high?
Ayurcann Holdings' current EV-to-FCF of 0.65 is 58% below median its 10-year median of 1.54. The Drug Manufacturers industry median EV-to-FCF is 20.53. Ayurcann Holdings' value of 0.65 is 96.8% below this industry median.
How does Ayurcann Holdings' EV-to-FCF compare to BSPK and SKYI?
Ayurcann Holdings' EV-to-FCF of 0.65 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-FCF is 20.53. Ayurcann Holdings' value of 0.65 is 96.8% below this benchmark. While the company's 10-year median is 1.54 vs. the industry median of 20.53, Ayurcann Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.53, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ayurcann Holdings's current EV-to-FCF of 0.65 is 96.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Ayurcann Holdings and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ayurcann Holdings's current EV-to-FCF is 0.65, which is 58% below median its own 10-year median of 1.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ayurcann Holdings stock overvalued right now?
Ayurcann Holdings (AYURF) has a current EV-to-FCF of 0.65. The stock's GF Value™ is $0.01, compared to a current price of $0.00 — trading 79% below its estimated fair value. The current EV-to-FCF is 0.65, which is 58% below median its 10-year median of 1.54 and 96.8% below the Drug Manufacturers industry median of 20.53. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Ayurcann Holdings (AYURF), the current EV-to-FCF is 0.65 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ayurcann Holdings Corp is engaged in providing post-harvest outsourcing solutions to licensed cannabis producers and the manufacture and distribution of cannabis products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AYURF has been successfully added to your 